Jazz Pharmaceuticals plc — Director's Dealing 2015

Oct 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-10-05

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-05	Ordinary Shares	S	2102	$132.255	Disposed	262594	Indirect
2015-10-05	Ordinary Shares	S	4193	$132.9392	Disposed	258401	Indirect
2015-10-05	Ordinary Shares	S	1225	$134.3172	Disposed	257176	Indirect
2015-10-05	Ordinary Shares	S	490	$135.726	Disposed	256686	Indirect
2015-10-05	Ordinary Shares	S	1695	$136.6018	Disposed	254991	Indirect
2015-10-05	Ordinary Shares	S	99	$137.81	Disposed	254892	Indirect
2015-10-05	Ordinary Shares	S	43	$132.256	Disposed	5261	Indirect
2015-10-05	Ordinary Shares	S	83	$132.939	Disposed	5178	Indirect
2015-10-05	Ordinary Shares	S	25	$134.3172	Disposed	5153	Indirect
2015-10-05	Ordinary Shares	S	10	$135.726	Disposed	5143	Indirect
2015-10-05	Ordinary Shares	S	34	$136.6041	Disposed	5109	Indirect
2015-10-05	Ordinary Shares	S	1	$137.81	Disposed	5108	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1734	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.71 to $132.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.

F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.73 to $133.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.85 to $134.71. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.10 to $136.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $136.29 to $136.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.71 to $132.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.73 to $133.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F9: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.85 to $134.71. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F10: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.10 to $136.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F11: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $136.29 to $136.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.